Advertisement

Panniculitis

  • Mark C. MochelEmail author
  • Mariangela E. A. Marques
  • Mai P. Hoang
Chapter
  • 79 Downloads

Abstract

The histopathologic diagnosis of panniculitis requires both careful morphologic assessment and close clinical correlation. The pathologist encountering a biopsy for panniculitis may narrow a differential diagnosis by utilizing an algorithmic approach, typified by classification as either a mostly septal versus mostly lobular pattern, assessment for the presence or absence of vasculitis, and characterization of predominant inflammatory cell types. In addition to these general patterns, there are some features, such as the hyalinized fat necrosis of lupus panniculitis, which enable a specific diagnosis to be made. As described in this chapter, consideration of these histopathologic details, paired with close clinical correlation, allows for both specific diagnoses of panniculitis and reasonable differential diagnoses in those cases defying simple classification.

Keywords

Panniculitis Septal Lobular Erythema nodosum Lupus panniculitis Lipoatrophy Depositional panniculitis 

References

  1. 1.
    Requena L, Yus ES. Panniculitis. Part I. mostly septal panniculitis. J Am Acad Dermatol. 2001;45(2):163–83; quiz 84–6CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Requena L, Yus ES. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol. 2001;45(3):325–64.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Niemi KM, Forstrom L, Hannuksela M, Mustakallio KK, Salo OP. Nodules on the legs. A clinical, histological and immunohistological study of 82 patients representing different types of nodular panniculitis. Acta Derm Venereol. 1977;57(2):145–54.PubMedPubMedCentralGoogle Scholar
  4. 4.
    Reed RJ, Clark WH, Mihm MC. Disorders of the panniculus adiposus. Hum Pathol. 1973;4(2):219–29.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    White JW Jr, Winkelmann RK. Weber-Christian panniculitis: a review of 30 cases with this diagnosis. J Am Acad Dermatol. 1998;39(1):56–62.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Cribier B, Caille A, Heid E, Grosshans E. Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol. 1998;37(9):667–72.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Mert A, Kumbasar H, Ozaras R, Erten S, Tasli L, Tabak F, et al. Erythema nodosum: an evaluation of 100 cases. Clin Exp Rheumatol. 2007;25(4):563–70.PubMedPubMedCentralGoogle Scholar
  8. 8.
    Mossner R, Zimmer L, Berking C, Hoeller C, Loquai C, Richtig E, et al. Erythema nodosum-like lesions during BRAF inhibitor therapy: report on 16 new cases and review of the literature. J Eur Acad Dermatol Venereol. 2015;29(9):1797–806.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Coleman EL, Cowper SE, Stein SM, Leventhal JS. Erythema nodosum-like eruption in the setting of sorafenib therapy. JAMA Dermatol. 2018;154(3):369–70.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Tetzlaff MT, Jazaeri AA, Torres-Cabala CA, Korivi BR, Landon GA, Nagarajan P, et al. Erythema nodosum-like panniculitis mimicking disease recurrence: a novel toxicity from immune checkpoint blockade therapy-report of 2 patients. J Cutan Pathol. 2017;44(12):1080–6.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    De Simone C, Caldarola G, Scaldaferri F, Petito V, Perino F, Arena V, et al. Clinical, histopathological, and immunological evaluation of a series of patients with erythema nodosum. Int J Dermatol. 2016;55(5):e289–94.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Thurber S, Kohler S. Histopathologic spectrum of erythema nodosum. J Cutan Pathol. 2006;33(1):18–26.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    de Almeida Prestes C, Winkelmann RK, Su WP. Septal granulomatous panniculitis: comparison of the pathology of erythema nodosum migrans (migratory panniculitis) and chronic erythema nodosum. J Am Acad Dermatol. 1990;22(3):477–83.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Chan MP. Neutrophilic panniculitis: algorithmic approach to a heterogeneous group of disorders. Arch Pathol Lab Med. 2014;138(10):1337–43.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Egawa T, Okuyama R, Tagami H, Aiba S. Erythema nodosum with eosinophilic panniculitis. Int J Dermatol. 2010;49(8):965–7.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Kim B, LeBoit PE. Histopathologic features of erythema nodosum--like lesions in Behcet disease: a comparison with erythema nodosum focusing on the role of vasculitis. Am J Dermatopathol. 2000;22(5):379–90.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Braunstein I, Werth VP. Update on management of connective tissue panniculitides. Dermatol Ther. 2012;25(2):173–82.CrossRefPubMedPubMedCentralGoogle Scholar
  18. 18.
    Su WP, Person JR. Morphea profunda. A new concept and a histopathologic study of 23 cases. Am J Dermatopathol. 1981;3(3):251–60.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Almeida MS, Lima SC, Carvalho LL, Almeida JV, Santos LG, Rolim JR, et al. Panniculitis-an unusual cutaneous manifestation of systemic sclerosis. J Cutan Pathol. 2010;37(11):1170–3.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Peters MS, Su WP. Eosinophils in lupus panniculitis and morphea profunda. J Cutan Pathol. 1991;18(3):189–92.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Mertens JS, Seyger MMB, Thurlings RM, Radstake T, de Jong E. Morphea and eosinophilic fasciitis: an update. Am J Clin Dermatol. 2017;18(4):491–512.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Mazori DR, Femia AN, Vleugels RA. Eosinophilic fasciitis: an updated review on diagnosis and treatment. Curr Rheumatol Rep. 2017;19(12):74.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Winkelmann RK, Grado GL, Quimby SR, Connolly SM. Pseudosclerodermatous panniculitis after irradiation: an unusual complication of megavoltage treatment of breast carcinoma. Mayo Clin Proc. 1993;68(2):122–7.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Pielasinski U, Machan S, Camacho D, Juarez A, Cedeno M, Macia JA, et al. Postirradiation pseudosclerodermatous panniculitis: three new cases with additional histopathologic features supporting the radiotherapy etiology. Am J Dermatopathol. 2013;35(1):129–34.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Sandoval M, Giesen L, Cataldo K, Gonzalez S. Postirradiation pseudosclerodermatous panniculitis of the leg: report of a case and review of the literature. Am J Dermatopathol. 2015;37(7):587–9.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Carrasco L, Moreno C, Pastor MA, Izquierdo MJ, Farina C, Martin L, et al. Postirradiation pseudosclerodermatous panniculitis. Am J Dermatopathol. 2001;23(4):283–7.CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Dalle S, Skowron F, Ronger-Savle S, Balme B, Thomas L. Pseudosclerodermatous panniculitis after irradiation and bronchiolitis obliterans organizing pneumonia: simultaneous onset suggesting a common origin. Dermatology. 2004;209(2):138–41.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Walsh N, Rheaume D, Barnes P, Tremaine R, Reardon M. Postirradiation morphea: an underrecognized complication of treatment for breast cancer. Hum Pathol. 2008;39(11):1680–8.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Eklof B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg. 2004;40(6):1248–52.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Samlaska CP. Protein C and protein S plasma levels in patients with lipodermatosclerosis and venous ulceration. Arch Dermatol. 1991;127(6):908–9.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Bergan J. Molecular mechanisms in chronic venous insufficiency. Ann Vasc Surg. 2007;21(3):260–6.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Miteva M, Romanelli P, Kirsner RS. Lipodermatosclerosis. Dermatol Ther. 2010;23(4):375–88.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Alegre VA, Winkelmann RK, Aliaga A. Lipomembranous changes in chronic panniculitis. J Am Acad Dermatol. 1988;19(1 Pt 1):39–46.CrossRefPubMedPubMedCentralGoogle Scholar
  34. 34.
    Jorizzo JL, White WL, Zanolli MD, Greer KE, Solomon AR, Jetton RL. Sclerosing panniculitis. A clinicopathologic assessment. Arch Dermatol. 1991;127(4):554–8.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Huang TM, Lee JY. Lipodermatosclerosis: a clinicopathologic study of 17 cases and differential diagnosis from erythema nodosum. J Cutan Pathol. 2009;36(4):453–60.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Mochel MC, Arakaki RY, Wang G, Kroshinsky D, Hoang MP. Cutaneous calciphylaxis: a retrospective histopathologic evaluation. Am J Dermatopathol. 2013;35(5):582–6.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Diaz-Cascajo C, Borghi S. Subcutaneous pseudomembranous fat necrosis: new observations. J Cutan Pathol. 2002;29(1):5–10.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Segura S, Pujol RM, Trindade F, Requena L. Vasculitis in erythema induratum of Bazin: a histopathologic study of 101 biopsy specimens from 86 patients. J Am Acad Dermatol. 2008;59(5):839–51.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Baselga E, Margall N, Barnadas MA, Coll P, de Moragas JM. Detection of Mycobacterium tuberculosis DNA in lobular granulomatous panniculitis (erythema induratum-nodular vasculitis). Arch Dermatol. 1997;133(4):457–62.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Westers-Attema A, van Tubergen A, Plasschaert H, van Marion AM, Frank J, Poblete-Gutierrez P. Nodular vasculitis in systemic lupus erythematosus. Int J Dermatol. 2008;47(Suppl 1):3–6.CrossRefPubMedPubMedCentralGoogle Scholar
  41. 41.
    Misago N, Narisawa Y. Erythema induratum (nodular vasculitis) associated with Crohn’s disease: a rare type of metastatic Crohn’s disease. Am J Dermatopathol. 2012;34(3):325–9.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Park SB, Chang IK, Im M, Lee Y, Kim CD, Seo YJ, et al. Nodular vasculitis that developed during Etanercept (Enbrel) treatment in a patient with psoriasis. Ann Dermatol. 2015;27(5):605–7.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Schneider JW, Jordaan HF, Geiger DH, Victor T, Van Helden PD, Rossouw DJ. Erythema induratum of Bazin. A clinicopathological study of 20 cases and detection of Mycobacterium tuberculosis DNA in skin lesions by polymerase chain reaction. Am J Dermatopathol. 1995;17(4):350–6.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Schneider JW, Jordaan HF. The histopathologic spectrum of erythema induratum of Bazin. Am J Dermatopathol. 1997;19(4):323–33.CrossRefPubMedPubMedCentralGoogle Scholar
  45. 45.
    Sunderkotter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, et al. Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheumatol. 2018;70(2):171–84.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Patterson JW, Brown PC, Broecker AH. Infection-induced panniculitis. J Cutan Pathol. 1989;16(4):183–93.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Delgado-Jimenez Y, Fraga J, Garcia-Diez A. Infective panniculitis. Dermatol Clin. 2008;26(4):471–80, viCrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Delgado-Jimenez Y, Fraga J, Requena C, Requena L, Aragues M, Fernandez Herrera J, et al. Acute bacterial septic vasculopathy. Int J Dermatol. 2013;52(9):1071–80.CrossRefPubMedPubMedCentralGoogle Scholar
  49. 49.
    Forstrom L, Winkelmann RK. Acute panniculitis: a clinical and histopathologic study of 34 cases. Arch Dermatol. 1977;113(7):909–17.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Magro CM, Dyrsen ME, Crowson AN. Acute infectious id panniculitis/panniculitic bacterid: a distinctive form of neutrophilic lobular panniculitis. J Cutan Pathol. 2008;35(10):941–6.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Tran TA, DuPree M, Carlson JA. Neutrophilic lobular (pustular) panniculitis associated with rheumatoid arthritis: a case report and review of the literature. Am J Dermatopathol. 1999;21(3):247–52.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Dyer JA, Guitart J, Klein-Gitelman M, Mancini AJ. Neutrophilic panniculitis in infancy: a cutaneous manifestation of juvenile rheumatoid arthritis. J Am Acad Dermatol. 2007;57(5 Suppl):S65–8.CrossRefPubMedPubMedCentralGoogle Scholar
  53. 53.
    Magro CM, Crowson AN. The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol. 2003;30(1):1–10.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Sawalha AH, Lutz BD, Chaudhary NA, Kern W, Harley JB, Greenfield RA. Panniculitis: a presenting manifestation of disseminated histoplasmosis in a patient with rheumatoid arthritis. J Clin Rheumatol. 2003;9(4):259–62.CrossRefPubMedPubMedCentralGoogle Scholar
  55. 55.
    Beltraminelli HS, Buechner SA, Hausermann P. Pancreatic panniculitis in a patient with an acinar cell cystadenocarcinoma of the pancreas. Dermatology. 2004;208(3):265–7.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Dahl PR, Su WP, Cullimore KC, Dicken CH. Pancreatic panniculitis. J Am Acad Dermatol. 1995;33(3):413–7.CrossRefPubMedPubMedCentralGoogle Scholar
  57. 57.
    Hughes SH, Apisarnthanarax P, Mullins F. Subcutaneous fat necrosis associated with pancreatic disease. Arch Dermatol. 1975;111(4):506–10.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Forstrom TL, Winkelmann RK. Acute, generalized panniculitis with amylase and lipase in skin. Arch Dermatol. 1975;111(4):497–502.Google Scholar
  59. 59.
    Narvaez J, Bianchi MM, Santo P, de la Fuente D, Rios-Rodriguez V, Bolao F, et al. Pancreatitis, panniculitis, and polyarthritis. Semin Arthritis Rheum. 2010;39(5):417–23.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    Ball NJ, Cowan BJ, Hashimoto SA. Lobular panniculitis at the site of subcutaneous interferon beta injections for the treatment of multiple sclerosis can histologically mimic pancreatic panniculitis. A study of 12 cases. J Cutan Pathol. 2009;36(3):331–7.CrossRefPubMedPubMedCentralGoogle Scholar
  61. 61.
    Blanco I, Lipsker D, Lara B, Janciauskiene S. Neutrophilic panniculitis associated with alpha-1-antitrypsin deficiency: an update. Br J Dermatol. 2016;174(4):753–62.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Smith KC, Su WP, Pittelkow MR, Winkelmann RK. Clinical and pathologic correlations in 96 patients with panniculitis, including 15 patients with deficient levels of alpha 1-antitrypsin. J Am Acad Dermatol. 1989;21(6):1192–6.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Johnson EF, Tolkachjov SN, Gibson LE. Alpha-1 antitrypsin deficiency panniculitis: clinical and pathologic characteristics of 10 cases. Int J Dermatol. 2018;57(8):952–8.Google Scholar
  64. 64.
    Su WP, Smith KC, Pittelkow MR, Winkelmann RK. Alpha 1-antitrypsin deficiency panniculitis: a histopathologic and immunopathologic study of four cases. Am J Dermatopathol. 1987;9(6):483–90.CrossRefPubMedPubMedCentralGoogle Scholar
  65. 65.
    Geller JD, Su WP. A subtle clue to the histopathologic diagnosis of early alpha 1-antitrypsin deficiency panniculitis. J Am Acad Dermatol. 1994;31(2 Pt 1):241–5.CrossRefPubMedPubMedCentralGoogle Scholar
  66. 66.
    Greene DN, Elliott-Jelf MC, Straseski JA, Grenache DG. Facilitating the laboratory diagnosis of alpha1-antitrypsin deficiency. Am J Clin Pathol. 2013;139(2):184–91.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Schreuer M, Jansen Y, Planken S, Chevolet I, Seremet T, Kruse V, et al. Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAF(V600)-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial. Lancet Oncol. 2017;18(4):464–72.CrossRefPubMedPubMedCentralGoogle Scholar
  68. 68.
    Choy B, Chou S, Anforth R, Fernandez-Penas P. Panniculitis in patients treated with BRAF inhibitors: a case series. Am J Dermatopathol. 2014;36(6):493–7.CrossRefPubMedPubMedCentralGoogle Scholar
  69. 69.
    Kim GH, Levy A, Compoginis G. Neutrophilic panniculitis developing after treatment of metastatic melanoma with vemurafenib. J Cutan Pathol. 2013;40(7):667–9.CrossRefPubMedPubMedCentralGoogle Scholar
  70. 70.
    Vazquez-Osorio I, Sanchez-Aguilar MD, Garcia-Rodino S, Suarez-Penaranda JM, Aliste C, Vazquez-Veiga H. Vemurafenib-induced neutrophilic panniculitis: a new case and review of the literature. Am J Dermatopathol. 2016;38(7):e93–6.CrossRefPubMedPubMedCentralGoogle Scholar
  71. 71.
    Ferreira J, Toda-Brito H, Moura MC, Sachse MF, Costa-Rosa J. BRAFi-associated panniculitis – an emerging side effect with a variable histological picture: report of two cases and review of the literature. J Cutan Pathol. 2017;44(3):307–9.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Ramani NS, Curry JL, Kapil J, Rapini RP, Tetzlaff MT, Prieto VG, et al. Panniculitis with necrotizing granulomata in a patient on BRAF inhibitor (dabrafenib) therapy for metastatic melanoma. Am J Dermatopathol. 2015;37(8):e96–9.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Richarz NA, Puig L, Perez N, Cuadra-Urteaga J, Elez E, Fernandez-Figueras MG. Vemurafenbi-induced histiocytoid neutrophilic panniculitis simulating myeloid leukaemic cutis. . Cancer Biol Ther 2019;20(3):237–9.Google Scholar
  74. 74.
    Hasegawa M, Sato S, Nakada M, Nitta H, Shirasaki H, Kasahara K, et al. Sweet’s syndrome associated with granulocyte colony-stimulating factor. Eur J Dermatol. 1998;8(7):503–5.PubMedPubMedCentralGoogle Scholar
  75. 75.
    Jagdeo J, Campbell R, Long T, Muglia J, Telang G, Robinson-Bostom L. Sweet’s syndrome--like neutrophilic lobular panniculitis associated with all-trans-retinoic acid chemotherapy in a patient with acute promyelocytic leukemia. J Am Acad Dermatol. 2007;56(4):690–3.CrossRefPubMedPubMedCentralGoogle Scholar
  76. 76.
    Nousari HC, Kimyai-Asadi A, Provost TT. Generalized lupus erythematosus profundus in a patient with genetic partial deficiency of C4. J Am Acad Dermatol. 1999;41(2 Pt 2):362–4.CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    Winkelmann RK. Panniculitis in connective tissue disease. Arch Dermatol. 1983;119(4):336–44.CrossRefPubMedPubMedCentralGoogle Scholar
  78. 78.
    Fraga J, Garcia-Diez A. Lupus erythematosus panniculitis. Dermatol Clin. 2008;26(4):453–63. viCrossRefPubMedPubMedCentralGoogle Scholar
  79. 79.
    Watanabe T, Tsuchida T. Lupus erythematosus profundus: a cutaneous marker for a distinct clinical subset? Br J Dermatol. 1996;134(1):123–5.CrossRefPubMedPubMedCentralGoogle Scholar
  80. 80.
    Sanchez NP, Peters MS, Winkelmann RK. The histopathology of lupus erythematosus panniculitis. J Am Acad Dermatol. 1981;5(6):673–80.CrossRefPubMedPubMedCentralGoogle Scholar
  81. 81.
    Winkelmann RK. Panniculitis and systemic lupus erythematosus. JAMA. 1970;211(3):472–5.CrossRefPubMedPubMedCentralGoogle Scholar
  82. 82.
    Santos-Briz A, Calle A, Linos K, Semans B, Carlson A, Sangueza OP, et al. Dermatomyositis panniculitis: a clinicopathological and immunohistochemical study of 18 cases. J Eur Acad Dermatol Venereol; 2018;32(8):1352–9.Google Scholar
  83. 83.
    Beacham BE, Cooper PH, Buchanan CS, Weary PE. Equestrian cold panniculitis in women. Arch Dermatol. 1980;116(9):1025–7.CrossRefPubMedPubMedCentralGoogle Scholar
  84. 84.
    West SE, McCalmont TH, North JP. Ice-pack dermatosis: a cold-induced dermatitis with similarities to cold panniculitis and perniosis that histopathologically resembles lupus. JAMA Dermatol. 2013;149(11):1314–8.CrossRefPubMedPubMedCentralGoogle Scholar
  85. 85.
    Stewart CL, Adler DJ, Jacobson A, Brod BA, Shinohara MM, Seykora JT, et al. Equestrian perniosis: a report of 2 cases and a review of the literature. Am J Dermatopathol. 2013;35(2):237–40.CrossRefPubMedPubMedCentralGoogle Scholar
  86. 86.
    Magro CM, Crowson AN, Kovatich AJ, Burns F. Lupus profundus, indeterminate lymphocytic lobular panniculitis and subcutaneous T-cell lymphoma: a spectrum of subcuticular T-cell lymphoid dyscrasia. J Cutan Pathol. 2001;28(5):235–47.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Liau JY, Chuang SS, Chu CY, Ku WH, Tsai JH, Shih TF. The presence of clusters of plasmacytoid dendritic cells is a helpful feature for differentiating lupus panniculitis from subcutaneous panniculitis-like T-cell lymphoma. Histopathology. 2013;62(7):1057–66.CrossRefPubMedPubMedCentralGoogle Scholar
  88. 88.
    Sitthinamsuwan P, Pattanaprichakul P, Treetipsatit J, Pongpruttipan T, Sukpanichnant S, Pincus LB, et al. Subcutaneous panniculitis-like T-cell lymphoma versus lupus erythematosus panniculitis: distinction by means of the periadipocytic cell proliferation index. Am J Dermatopathol. 2018;40(8):567–74.CrossRefPubMedPubMedCentralGoogle Scholar
  89. 89.
    Bosisio F, Boi S, Caputo V, Chiarelli C, Oliver F, Ricci R, et al. Lobular panniculitic infiltrates with overlapping histopathologic features of lupus panniculitis (lupus profundus) and subcutaneous T-cell lymphoma: a conceptual and practical dilemma. Am J Surg Pathol. 2015;39(2):206–11.CrossRefPubMedPubMedCentralGoogle Scholar
  90. 90.
    Harris RB, Duncan SC, Ecker RI, Winkelmann RK. Lymphoid follicles in subcutaneous inflammatory disease. Arch Dermatol. 1979;115(4):442–3.CrossRefPubMedPubMedCentralGoogle Scholar
  91. 91.
    Weber FP, Gray AMH. Chronic relapsing polydermatomyositis with predominant involvement of the subcutaneous fat (panniculitis). Br J Dermatol. 1924;36:544–60.CrossRefGoogle Scholar
  92. 92.
    Salman A, Kasapcopur O, Ergun T, Durmus Ucar AN, Demirkesen C. Panniculitis in juvenile dermatomyositis: report of a case and review of the published work. J Dermatol. 2016;43(8):951–3.CrossRefPubMedPubMedCentralGoogle Scholar
  93. 93.
    Solans R, Cortes J, Selva A, Garcia-Patos V, Jimenez FJ, Pascual C, et al. Panniculitis: a cutaneous manifestation of dermatomyositis. J Am Acad Dermatol. 2002;46(5 Suppl):S148–50.CrossRefPubMedPubMedCentralGoogle Scholar
  94. 94.
    Janis JF, Winkelmann RK. Histopathology of the skin in dermatomyositis. A histopathologic study of 55 cases. Arch Dermatol. 1968;97(6):640–50.CrossRefPubMedPubMedCentralGoogle Scholar
  95. 95.
    Labrador-Horrillo M, Martinez MA, Selva-O’Callaghan A, Trallero-Araguas E, Balada E, Vilardell-Tarres M, et al. Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis. J Immunol Res. 2014;2014:290797.CrossRefPubMedPubMedCentralGoogle Scholar
  96. 96.
    Fusade T, Belanyi P, Joly P, Thomine E, Mihout MF, Lauret P. Subcutaneous changes in dermatomyositis. Br J Dermatol. 1993;128(4):451–3.CrossRefPubMedPubMedCentralGoogle Scholar
  97. 97.
    Ter Poorten JC, Hebert AA, Ilkiw R. Cold panniculitis in a neonate. J Am Acad Dermatol. 1995;33(2 Pt 2):383–5.CrossRefPubMedPubMedCentralGoogle Scholar
  98. 98.
    Kluger N, Marty L, Bourseau-Quetier C, Blum M, Camus M. Perniosis/cold panniculitis in French equestrians: four cases. Int J Dermatol. 2016;55(12):e618–e20.CrossRefPubMedPubMedCentralGoogle Scholar
  99. 99.
    Duncan WC, Freeman RG, Heaton CL. Cold panniculitis. Arch Dermatol. 1966;94(6):722–4.CrossRefPubMedPubMedCentralGoogle Scholar
  100. 100.
    Kumar S, Krenacs L, Medeiros J, Elenitoba-Johnson KS, Greiner TC, Sorbara L, et al. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes. Hum Pathol. 1998;29(4):397–403.CrossRefPubMedPubMedCentralGoogle Scholar
  101. 101.
    Willemze R, Jaffe ES, Burg G, Cerroni L, Berti E, Swerdlow SH, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768–85.CrossRefPubMedPubMedCentralGoogle Scholar
  102. 102.
    Willemze R, Jansen PM, Cerroni L, Berti E, Santucci M, Assaf C, et al. Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases. Blood. 2008;111(2):838–45.CrossRefPubMedPubMedCentralGoogle Scholar
  103. 103.
    Kong YY, Dai B, Kong JC, Zhou XY, Lu HF, Shen L, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification. Am J Surg Pathol. 2008;32(10):1495–502.CrossRefPubMedPubMedCentralGoogle Scholar
  104. 104.
    Lee DW, Yang JH, Lee SM, Won CH, Chang S, Lee MW, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinical and pathologic study of 14 korean patients. Ann Dermatol. 2011;23(3):329–37.CrossRefPubMedPubMedCentralGoogle Scholar
  105. 105.
    Lopez-Lerma I, Penate Y, Gallardo F, Marti RM, Mitxelena J, Bielsa I, et al. Subcutaneous panniculitis-like T-cell lymphoma: clinical features, therapeutic approach, and outcome in a case series of 16 patients. J Am Acad Dermatol. 2018;79(5):892–8.CrossRefPubMedPubMedCentralGoogle Scholar
  106. 106.
    Hoque SR, Child FJ, Whittaker SJ, Ferreira S, Orchard G, Jenner K, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol. 2003;148(3):516–25.CrossRefPubMedPubMedCentralGoogle Scholar
  107. 107.
    Massone C, Chott A, Metze D, Kerl K, Citarella L, Vale E, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol. 2004;28(6):719–35.CrossRefPubMedPubMedCentralGoogle Scholar
  108. 108.
    Willemze R. Cutaneous lymphomas with a panniculitic presentation. Semin Diagn Pathol. 2017;34(1):36–43.CrossRefPubMedPubMedCentralGoogle Scholar
  109. 109.
    LeBlanc RE, Tavallaee M, Kim YH, Kim J. Useful parameters for distinguishing subcutaneous panniculitis-like T-cell lymphoma from lupus erythematosus panniculitis. Am J Surg Pathol. 2016;40(6):745–54.CrossRefPubMedPubMedCentralGoogle Scholar
  110. 110.
    Sanmartin O, Requena C, Requena L. Factitial panniculitis. Dermatol Clin. 2008;26(4):519–27, viiiCrossRefPubMedPubMedCentralGoogle Scholar
  111. 111.
    Winkelmann RK, Barker SM. Factitial traumatic panniculitis. J Am Acad Dermatol. 1985;13(6):988–94.CrossRefPubMedPubMedCentralGoogle Scholar
  112. 112.
    Klein JA, Cole G, Barr RJ, Bartlow G, Fulwider C. Paraffinomas of the scalp. Arch Dermatol. 1985;121(3):382–5.CrossRefPubMedPubMedCentralGoogle Scholar
  113. 113.
    Oertel YC, Johnson FB. Sclerosing lipogranuloma of male genitalia. Review of 23 cases. Arch Pathol Lab Med. 1977;101(6):321–6.PubMedPubMedCentralGoogle Scholar
  114. 114.
    Requena C, Izquierdo MJ, Navarro M, Martinez A, Vilata JJ, Botella R, et al. Adverse reactions to injectable aesthetic microimplants. Am J Dermatopathol. 2001;23(3):197–202.CrossRefPubMedPubMedCentralGoogle Scholar
  115. 115.
    Del Pozzo-Magana BR, Ho N. Subcutaneous fat necrosis of the newborn: a 20-year retrospective study. Pediatr Dermatol. 2016;33(6):e353–e5.CrossRefPubMedPubMedCentralGoogle Scholar
  116. 116.
    Muzy G, Mayor SAS, Lellis RF. Subcutaneous fat necrosis of the newborn: clinical and histopathological correlation. An Bras Dermatol. 2018;93(3):412–4.CrossRefPubMedPubMedCentralGoogle Scholar
  117. 117.
    Stefanko NS, Drolet BA. Subcutaneous fat necrosis of the newborn and associated hypercalcemia: a systematic review of the literature. Pediatr Dermatol. 2019;36(1):24–30.CrossRefPubMedPubMedCentralGoogle Scholar
  118. 118.
    Tajirian A, Ross R, Zeikus P, Robinson-Bostom L. Subcutaneous fat necrosis of the newborn with eosinophilic granules. J Cutan Pathol. 2007;34(7):588–90.CrossRefPubMedPubMedCentralGoogle Scholar
  119. 119.
    Ricardo-Gonzalez RR, Lin JR, Mathes EF, McCalmont TH, Pincus LB. Neutrophil-rich subcutaneous fat necrosis of the newborn: a potential mimic of infection. J Am Acad Dermatol. 2016;75(1):177–85 e17.CrossRefPubMedPubMedCentralGoogle Scholar
  120. 120.
    Zeb A, Darmstadt GL. Sclerema neonatorum: a review of nomenclature, clinical presentation, histological features, differential diagnoses and management. J Perinatol. 2008;28(7):453–60.CrossRefPubMedPubMedCentralGoogle Scholar
  121. 121.
    Kwon EJ, Emanuel PO, Gribetz CH, Mudgil AV, Phelps RG. Poststeroid panniculitis. J Cutan Pathol. 2007;34(Suppl 1):64–7.CrossRefPubMedPubMedCentralGoogle Scholar
  122. 122.
    Llamas-Velasco M, Requena L. Panniculitis with crystals induced by etanercept subcutaneous injection. J Cutan Pathol. 2015;42(6):413–5.CrossRefPubMedPubMedCentralGoogle Scholar
  123. 123.
    Mir-Bonafe JM, Roman-Curto C, Santos-Briz A, Canueto J, Fernandez-Lopez E, Unamuno P. Gemcitabine-associated livedoid thrombotic microangiopathy with associated sclerema neonatorum-like microscopic changes. J Cutan Pathol. 2012;39(7):707–11.CrossRefPubMedPubMedCentralGoogle Scholar
  124. 124.
    Garg A. Acquired and inherited lipodystrophies. N Engl J Med. 2004;350(12):1220–34.CrossRefPubMedPubMedCentralGoogle Scholar
  125. 125.
    Billings JK, Milgraum SS, Gupta AK, Headington JT, Rasmussen JE. Lipoatrophic panniculitis: a possible autoimmune inflammatory disease of fat. Report of three cases. Arch Dermatol. 1987;123(12):1662–6.CrossRefPubMedPubMedCentralGoogle Scholar
  126. 126.
    Misra A, Peethambaram A, Garg A. Clinical features and metabolic and autoimmune derangements in acquired partial lipodystrophy: report of 35 cases and review of the literature. Medicine (Baltimore). 2004;83(1):18–34.CrossRefGoogle Scholar
  127. 127.
    Gomes KB, Pardini VC, Fernandes AP. Clinical and molecular aspects of Berardinelli-Seip Congenital Lipodystrophy (BSCL). Clin Chim Acta. 2009;402(1–2):1–6.CrossRefPubMedPubMedCentralGoogle Scholar
  128. 128.
    Herbst KL, Tannock LR, Deeb SS, Purnell JQ, Brunzell JD, Chait A. Kobberling type of familial partial lipodystrophy: an underrecognized syndrome. Diabetes Care. 2003;26(6):1819–24.CrossRefPubMedPubMedCentralGoogle Scholar
  129. 129.
    Peters MS, Winkelmann RK. Localized lipoatrophy (atrophic connective tissue disease panniculitis). Arch Dermatol. 1980;116(12):1363–8.CrossRefPubMedPubMedCentralGoogle Scholar
  130. 130.
    Dahl PR, Zalla MJ, Winkelmann RK. Localized involutional lipoatrophy: a clinicopathologic study of 16 patients. J Am Acad Dermatol. 1996;35(4):523–8.CrossRefPubMedPubMedCentralGoogle Scholar
  131. 131.
    Tsuji T, Kosaka K, Terao J. Localized lipodystrophy with panniculitis: light and electron microscopic studies. J Cutan Pathol. 1989;16(6):359–64.CrossRefPubMedPubMedCentralGoogle Scholar
  132. 132.
    Essary LR, Wick MR. Cutaneous calciphylaxis. An underrecognized clinicopathologic entity. Am J Clin Pathol. 2000;113(2):280–7.CrossRefPubMedPubMedCentralGoogle Scholar
  133. 133.
    LeBoit PE, Schneider S. Gout presenting as lobular panniculitis. Am J Dermatopathol. 1987;9(4):334–8.CrossRefPubMedPubMedCentralGoogle Scholar
  134. 134.
    Shih HA, Kao DM, Elenitsas R, Leyden JJ. Livedo reticularis, ulcers, and peripheral gangrene: cutaneous manifestations of primary hyperoxaluria. Arch Dermatol. 2000;136(10):1272–4.CrossRefPubMedPubMedCentralGoogle Scholar
  135. 135.
    Blackmon JA, Jeffy BG, Malone JC, Knable AL Jr. Oxalosis involving the skin: case report and literature review. Arch Dermatol. 2011;147(11):1302–5.CrossRefPubMedPubMedCentralGoogle Scholar
  136. 136.
    Dogan S, Barnes L, Cruz-Vetrano WP. Crystal-storing histiocytosis: report of a case, review of the literature (80 cases) and a proposed classification. Head Neck Pathol. 2012;6(1):111–20.CrossRefPubMedPubMedCentralGoogle Scholar
  137. 137.
    Li JJ, Henderson C. Cutaneous crystal storing histiocytosis: a report of two cases. J Cutan Pathol. 2015;42(2):136–43.CrossRefPubMedPubMedCentralGoogle Scholar
  138. 138.
    Sarno EN, Grau GE, Vieira LM, Nery JA. Serum levels of tumor necrosis factor–alpha and interleukin-1 beta during leprosy reactional states. Clin Exp Immunol. 1991;84(1):103–8.PubMedPubMedCentralGoogle Scholar
  139. 139.
    Massone C, Belachew WA, Schettini A. Histopathology of the lepromatous skin biopsy. Clin Dermatol. 2015;33(1):38–45.CrossRefPubMedPubMedCentralGoogle Scholar
  140. 140.
    Colley DG, Bustinduy AL, Secor WE, King CH. Human schistosomiasis. Lancet. 2014;383(9936):2253–64.CrossRefPubMedPubMedCentralGoogle Scholar
  141. 141.
    Barsoum RS, Esmat G, El-Baz T. Human schistosomiasis: clinical perspective. Review. J Adv Res. 2013;4(5):433–44.CrossRefPubMedPubMedCentralGoogle Scholar
  142. 142.
    Poggensee G, Feldmeier H. Female genital schistosomiasis: facts and hypotheses. Acta Trop. 2001;79(3):193–210.CrossRefPubMedPubMedCentralGoogle Scholar
  143. 143.
    Marcoval J, Mana J, Moreno A, Peyri J. Subcutaneous sarcoidosis--clinicopathological study of 10 cases. Br J Dermatol. 2005;153(4):790–4.CrossRefPubMedPubMedCentralGoogle Scholar
  144. 144.
    Ando M, Miyazaki E, Hatano Y, Nishio S, Torigoe C, Yamasue M, et al. Subcutaneous sarcoidosis: a clinical analysis of nine patients. Clin Rheumatol. 2016;35(9):2277–81.CrossRefPubMedPubMedCentralGoogle Scholar
  145. 145.
    Altmeyer MD, Anderson LL, Wang AR. Silicone migration and granuloma formation. J Cosmet Dermatol. 2009;8(2):92–7.CrossRefPubMedPubMedCentralGoogle Scholar
  146. 146.
    Park ME, Curreri AT, Taylor GA, Burris K. Silicone granulomas, a growing problem? J Clin Aesthet Dermatol. 2016;9(5):48–51.PubMedPubMedCentralGoogle Scholar
  147. 147.
    Zappi E, Barnett JG, Zappi M, Barnett CR. The long-term host response to liquid silicone injected during soft tissue augmentation procedures: a microscopic appraisal. Dermatol Surg. 2007;33(Suppl 2):S186–92.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Mark C. Mochel
    • 1
    Email author
  • Mariangela E. A. Marques
    • 2
  • Mai P. Hoang
    • 3
  1. 1.Departments of Pathology and DermatologyVirginia Commonwealth University Health SystemRichmondUSA
  2. 2.Department of PathologyMedical School of São Paulo State UniversityBotucatuBrazil
  3. 3.Department of PathologyMassachusetts General Hospital and Harvard Medical SchoolBostonUSA

Personalised recommendations